Questions are swirling around the use of semaglutide, commonly sold under the brand name Ozempic, for weight loss. CBC’s Christine Birak explores







Ozempic for weight loss: What's known about the potential and the risks [ptCLjQWP0bS]

Ozempic for weight loss: What's known about the potential and the risks [ptCLjQWP0bS]

| 1h 28m 28s | Video has closed captioning.

Questions are swirling around the use of semaglutide, commonly sold under the brand name Ozempic, for weight loss. CBC’s Christine Birak explores the risks and benefits of off-label uses of the drug, which is traditionally used to treat Type 2 diabetes. #Weightloss #Ozempic #health Watch The National live on YouTube Sunday-Friday at 9 p.m. ET Subscribe to The National: Connect with The National online: Facebook | Twitter | Instagram | More from CBC News | The National is the flagship of CBC News, showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault and Ian Hanomansing, our team of trusted reporters help you make sense of the world, wherever you are. The National was named Canada’s Best National Newscast by the Canadian Screen Awards and RTDNA Canada. #k3 gummies for weight loss #keto gummies evidence #how to return keto acv gummies

Aired: January 07, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now